| Trial ID: | L0118 |
| Source ID: | NCT02068339
|
| Associated Drug: |
Oltipraz
|
| Title: |
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcholic Fatty Liver Disease
|
| Interventions: |
Drug: Oltipraz 1 (90mg)|Drug: Placebo|Drug: Oltipraz 2 (120mg)
|
| Outcome Measures: |
MRS(magnetic resonance spectroscopy)|change in liver fat concentration|change in BMI|change in NAFLD Fibrosis score (NFS)|change in ALT, AST, ??-GT|change in Cholesterol (total, LDL, HDL, VLDL), Triglyceride (TG)|change in HOMA-IR|change in waist circumference
|
| Sponsor/Collaborators: |
PharmaKing
|
| Gender: |
All
|
| Age: |
19 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 3
|
| Enrollment: |
283
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
February 2014
|
| Completion Date: |
March 2016
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 30, 2016
|
| Locations: |
NHUS Ilsan Hospital, Ilsan-ro Ilsan-donggu, Goyang-si, Korea, Republic of|Inje University Ilsan Paik Hospital, Dahwa-dong, Ilsanseo-gu, Goyang-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Daehak-ro Jongno-gu, Seoul, Korea, Republic of|Korea University Guro hospital, Gurodong-ro, Seoul, Korea, Republic of|Boramae Hospital, Sindaebang-dong Dongjak-gu, Seoul, Korea, Republic of
|
| URL: |
https://ClinicalTrials.gov/show/NCT02068339
|
